Founded in 2007, Burjeel Holdings is a leading super-specialty healthcare services provider in the UAE and Oman, with a growing specialized healthcare segment in Saudi Arabia. The Group operates an integrated, multi-brand healthcare ecosystem spanning primary, secondary, tertiary, and quaternary care, enabling the delivery of advanced and complex care to patients across socioeconomic groups.

Its network comprises 89 assets across the UAE, Oman, and Saudi Arabia, including 20 hospitals, 43 medical centers and physiotherapy centers, 15 pharmacies, and 11 other allied services. Burjeel Holdings’ brands include Burjeel, Medeor, LLH, Lifecare, Alkalma, and Tajmeel.

Complex care is a key strategic focus for Burjeel Holdings, supported by advanced capabilities across oncology, transplantation, fetal medicine, orthopedics, and other highly specialized disciplines. The Group operates the region’s largest integrated cancer care network, providing access to advanced diagnostics, precision medicine, multidisciplinary treatment, and specialized oncology services.

Beyond clinical care, Burjeel Holdings is advancing healthcare through research, innovation, and the development of more resilient and accessible models of care. Its work spans precision medicine, clinical research, and technology-enabled healthcare. Through collaboration with global institutions, healthcare leaders, and research partners, the Group seeks to translate innovation into meaningful health outcomes for communities across the region and beyond.